Statistics for Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review.
Total visits
| views | |
|---|---|
| Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review. | 152 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Plavix PGx manuscript_Main Text_clean revision.docx | 69 |
| Plavix PGx Sys Review_Supplement_clean revision.docx | 47 |
| java.util.UUID:b4a70ac3-d433-48f1-8f9f-de8d55bb405c | 36 |
| java.util.UUID:1cfa4df7-032c-4c2b-8005-f8c3ced3dd98 | 34 |
| Plavix PGx Sys Review_Tables.docx | 29 |
| java.util.UUID:f7bd563d-0819-4c87-9fee-ab64f6675091 | 26 |
| java.util.UUID:811f2d5a-e285-48c0-8e36-3b2208d28fea | 7 |
Top country views
| views | |
|---|---|
| United States | 99 |
| Canada | 10 |
| China | 4 |
| Germany | 3 |
| Netherlands | 3 |
| Brazil | 2 |
| India | 2 |
| South Korea | 2 |
| Switzerland | 1 |
| United Kingdom | 1 |
| Malaysia | 1 |
| New Zealand | 1 |
| Qatar | 1 |
| Singapore | 1 |
| Slovenia | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 45 |
| White Plains | 9 |
| Toronto | 7 |
| Fairfield | 6 |
| Fort Wayne | 6 |
| Houston | 5 |
| Ann Arbor | 3 |
| Baltimore | 3 |
| Bristol | 3 |
| Port Saint Lucie | 3 |
| Beijing | 2 |
| Brasília | 2 |
| Cambridge | 2 |
| Indianapolis | 2 |
| Lake Mary | 2 |
| Munich | 2 |
| Ottawa | 2 |
| Utrecht | 2 |
| Ashburn | 1 |
| Auckland | 1 |
| Bailey | 1 |
| Bloomington | 1 |
| Concord | 1 |
| Delhi | 1 |
| Doha | 1 |
| Kiev | 1 |
| Kiez | 1 |
| Kuala Lumpur | 1 |
| Ljubljana | 1 |
| Mount Laurel | 1 |
| New Delhi | 1 |
| New York | 1 |
| Seoul | 1 |
| Sherwood Park | 1 |
| Singapore | 1 |
| Tianjin | 1 |
| Warrington | 1 |
| Zürich | 1 |